Areas of Focus:

Academia–Industry PartnershipsAutoantibodiesAutoantigensAutoimmune EpidemiologyB Cell BiologyBiological & MechanisticBiomarker DiscoveryClinical TrialsCollaboration & InnovationCross-institutional CollaborationCytokine SignalingExperimental Platforms & ModelsHuman CohortsIn Vitro ModelsPopulation & Patient-CenteredTherapeutic DevelopmentTranslational & ClinicalAutoimmunity in PregnancyCross-Cutting & Special PopulationsSjögren’s DiseaseSystemic DiseasesSystemic Lupus Erythematosus (SLE)
  • Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health
  • Director, Division of Rheumatology, NYU Grossman School of Medicine / NYU Langone Health
  • Director, Lupus Center, NYU Grossman School of Medicine / NYU Langone Health
  • Co-Director, Judith & Stewart Colton Center for Autoimmunity, NYU Grossman School of Medicine / NYU Langone Health

Dr. Jill P. Buyon is the Sir Deryck and Lady Va Maughan Professor of Rheumatology, Director of the Division of Rheumatology, and Co-Director of the Colton Center for Autoimmunity at NYU Grossman School of Medicine, where she also directs the NYU Lupus Center. She earned her MD from the Albert Einstein College of Medicine, completed her residency in internal medicine at Bronx Municipal Hospital Center, and her rheumatology fellowship at NYU, where she has remained throughout her career.

An internationally recognized physician-scientist, Dr. Buyon specializes in translational research and the clinical management of systemic lupus erythematosus (SLE), lupus nephritis, neonatal lupus, and rheumatic diseases in pregnancy. She founded the Research Registry for Neonatal Lupus in 1994, which has generated over 100 publications, and has led landmark studies on the pathogenesis of fetal conduction disease, including demonstrating that hydroxychloroquine reduces the recurrence of congenital heart block by 50%. She led the first multicenter SLE study supported by NIAMS, which produced a paradigm shift regarding the safety of contraceptive estrogens in lupus patients.

Dr. Buyon oversees the P50 COMPEL translational center and has established SAMPLE, a biorepository integrating phenotype and biospecimen data to facilitate lupus research. She is co-editor-in-chief of Lupus Science and Medicine, has published more than 200 peer-reviewed papers, and has been elected to the American Academy of Physicians. Her honors include the Distinguished Clinical Investigator Award, the Evelyn V. Hess Lifetime Achievement Award, and the Halsted R. Holman Award for Excellence in Clinical Research.